Respiratory Syncytial Virus (RSV)
4,466 views
Viruses - RNA Viruses
- HIV: Microbiology and Characteristics
- HIV: Clinical Course
- Reovirus
- Picornavirus Overview
- Poliovirus
- Echovirus
- Rhinovirus
- Coxsackievirus
- Hepatitis A Virus (HAV)
- Hepevirus (Hepatitis E Virus)
- Calicivirus
- Flavivirus
- Hepatitis C Virus (HCV)
- Yellow Fever Virus
- Dengue Virus
- St. Louis Encephalitis and West Nile Virus
- Zika Virus
- Togavirus
- Rubella
- Retrovirus
- Coronavirus
- Orthomyxovirus
- Paramyxovirus
- Respiratory Syncytial Virus (RSV)
- Parainfluenza Virus (Croup)
- Measles
- Mumps
- Rhabdovirus
- Filovirus
- Arenavirus
- Bunyavirus
- Deltavirus
Summary
RSV is a paramyxovirus that can cause bronchitis and bronchiolitis in young infants. It’s especially dangerous in the winter time, when the cold further weakens the immune system. To treat an RSV infection, clinicians can administer either palivizumab or ribavirin.
Key Points
- Respiratory syncytial virus (RSV) and Human metapneumovirus (hMPV)
- Transmission
- Respiratory droplets
- Presentation
- bronchitis/bronchiolitis in infants
- Diagnosis
- RT-PCR is standard
- Treatment
- Primarily supportive
- Palivizumab may be used
- Monoclonal antibody against F protein
- Prevents pneumonia by RSV infection in premature infants
- Ribavirin may be used
- Nucleoside antimetabolite that interferes with viral genetic replication
- Palivizumab may be used
- Primarily supportive
- Transmission